Pharmaceuticals – one of the hottest sectors of 2014 – has continued with its winning momentum this year as well on the back of several mergers and acquisitions. Moreover, impressive earnings in Q1 have helped to keep up the trend.
In trading on Monday, drugs shares were relative leaders, up on the day by about 1.1%. Leading the group were shares of Versartis (VSAR), up about 20.3% and shares of Eagle Pharmaceuticals (EGRX) up about 7% on the day.
NEW YORK (TheStreet) -- Rock Creek Pharmaceuticals
shares are jumping 19.13% to $1.81 on heavy volume Wednesday after the company announced the results of its human proof of principle study of its chronic inflammatory disease and neurologic...
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) and Xenon
Pharmaceuticals Inc. (XENE) reported results from the double-blind,
placebo-controlled Phase 2b study designed to evaluate the safety and efficacy
of topically applied...
Biotest AG: Biotest and CEVEC Pharmaceuticals enter into a License Agreement
regarding a cell line system for the production of tailor-made proteins
DGAP-News: Biotest AG / Key word(s): Alliance
Biotest AG: Biotest and CEVEC Pharmaceuticals enter...
Oops! Unable to complete your request. Please refresh your browser.